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Abstract
Background: The role of goal-directed therapy (GDT) in preventing creatinine rise following noncardiac surgery is unclear.
We performed a post-hoc analysis of a randomized controlled trial to assess the relationship between postoperative optimi-
zation of oxygen delivery and development of acute kidney injury (AKI)/creatinine rise following noncardiac surgery.
Methods: Patients were randomly assigned immediately postoperatively to receive either fluid and/or dobutamine therapy
to maintain/restore their preoperative oxygen delivery, or protocolized standard care (oxygen delivery only recorded).
Primary end point was serial changes in postoperative creatinine within 48 h postoperatively. Secondary outcomes were
development of AKI (KDIGO criteria) and minimal creatinine rise (MCR; no decline from preoperative creatinine), related to
all-cause morbidity and length of stay.
Results: Postoperative reductions in serum creatinine were similar (P¼0.76) in patients randomized to GDT [10 mmol/L (95%
confidence interval, CI: 17 to1); n¼95] or protocolized care [8 mmol/L (95% CI: 17 to6); n¼92]. Postoperative haemody-
namic management was not associated with the development of MCR [78/187 (41.7%)] or AKI [13/187; (7.0%)]. Intraoperative
requirement for norepinephrine was more likely in patients who developed postoperative rises in creatinine [relative risk
(RR): 1.66 (95% CI: 1.04–2.67); P¼0.04], despite similar volumes of intraoperative fluid being administered. Persistently higher
lactate during the intervention period was associated with AKI (mean difference: 1.15 mmol/L (95% CI: 0.48–1.81); P¼0.01].
Prolonged hospital stay was associated with AKI but not MCR [RR: 2.71 (95% CI: 1.51–4.87); P¼0.0008].
Conclusion: These data provide further insights into how perioperative haemodynamic alterations relate to postoperative
increases in creatinine once systemic inflammation is established.
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Introduction
Acute kidney injury (AKI) following major surgery is associated
with excess morbidity and mortality [1–5]. Even subtle increases
in creatinine very early in the postoperative period that are indi-
cative of minor renal injury—termed minimal creatinine rise
(MCR)—are associated with worse outcomes, particularly fol-
lowing cardiac surgery [6, 7]. A systematic review concluded
that renal injury may be reduced by goal-directed haemody-
namic therapy in noncardiac surgery [8]. However, this system-
atic review also highlighted that detailed physiological
parameters were seldom reported—particularly in control
groups [8–10]. Although the deleterious effects of hypovolaemia
are established [11], unmonitored and overzealous fluid admin-
istration may also lead to tissue oedema and persistent multi-
organ dysfunction [12].
Here, we re-examined the findings of a randomized,
double-blinded controlled trial where the hypothesis was
tested that postoperative attainment of preoperative oxygen
delivery may reduce morbidity [13]. This further analysis was
undertaken to establish whether goal-directed therapy (GDT)
reduced early renal injury, as the collection of KDIGO criteria
for AKI [4] was undertaken prospectively. We also
characterized perioperative factors associated with changes in
creatinine within 48 h after major noncardiac surgery in a
higher-risk surgical population where oxygen delivery was
recorded before the onset of systemic inflammation.
Materials and methods
Study design and patients
This post-hoc analysis was undertaken using data obtained
prospectively from a multicentre, randomized, double blinded
trial (Trial Registration: ISRCTN76894700) at four hospitals in
the UK, comparing postoperative goal-directed haemodynamic
therapy aimed at restoring/preserving each patients’ individu-
alized preoperative oxygen delivery versus protocolized stand-
ard of care. This trial was approved by UK institutional review
[Outer South East London REC—South London REC Office [4],
approved on the 29 December 2009 (ref: 09/H0805/58)], com-
plied with the Declaration of Helsinki and the Declaration of
Istanbul and adhered to the International Conference on
Harmonisation Guidelines on Good Clinical Practice. Adult
patients undergoing major elective surgery expected to last for
at least 120 min were eligible for recruitment provided they
satisfied the following high-risk criteria: (i) ASAgrade3; (ii).
surgical procedures with an estimated/documented risk of
postoperative morbidity (as defined by the PostOperative
Morbidity Survey) exceeding 50%; (iii) modified Revised
Cardiac Risk Score3, as defined by age70 years, a history of
cardiovascular disease (myocardial infarction, coronary artery
disease, cerebrovascular accident, electrocardiographic evi-
dence for established cardiac pathology), cardiac failure, poor
exercise capacity (anaerobic threshold<11 mL/kg/min as
assessed by cardiopulmonary exercise testing), renal impair-
ment (serum creatinine130 mmol/L) and/or diabetes mellitus.
Intraoperative management was undertaken by consultant
anaesthetists, according to their usual practice. A protocol was
published online before trial completion (ucl.ac.uk/anaesthe
sia). Exclusion criteria included refusal of consent, pregnancy,
lithium therapy or allergy, recent myocardial ischaemia
(within previous 30 days), acute arrhythmia, acute bleeding
and patients receiving palliative treatment only. Before enrol-
ment, patients provided written informed consent.
Randomization and blinding
Patients were randomly assigned to either oxygen delivery tar-
get or protocolized care in a 1:1 ratio, stratified by operation
type (STATA software). Central allocation was undertaken, with
assignments concealed by envelope. Patients, attending physi-
cians and critical care staff were blinded to the patients’ treat-
ment assignments. Apart from the trial statistician and the
data-monitoring committee, all treating physicians and other
investigators remained blinded to the trial results until follow-
up was completed. Central venous catheterization was under-
taken after induction of anaesthesia. Postoperatively all
patients were admitted to a critical care facility. Here, a syringe
with saline or dobutamine unidentifiable to all staff other than
research personnel was connected via extension tubing to the
central venous catheter (or, exceptionally, large bore intrave-
nous cannula).
Procedures
The study was conducted from 20 May 2010 until 12 February
2014. Follow-up ceased when the last enrolled patient was dis-
charged from hospital. If patients developed pre-specified com-
plications intraoperatively, or the planned surgery was altered
as a result of intraoperative findings (e.g. unresectable tumour)
patients became ineligible (pre-specified criteria for exclusion
were published in online protocol). Calibrated cardiac output
monitoring (LiDCOPlus, LiDCO Ltd, London, UK) [14] was used to
calculate preoperative oxygen delivery by determining preoper-
ative cardiac output. Haemodynamic data were recorded intrao-
peratively but were permitted for use by operating room staff.
The intervention period commenced once the patient reached
the critical care environment after surgery and continued for
6 h. Both randomization arms (i.e. GDT and protocolized control
group allocated patients) were managed by research staff dur-
ing the postoperative study period. Haemodynamic manage-
ment was solely the remit of research staff during this 6 h
period. Post-operative analgesia was provided by thoracic epi-
dural or patient-controlled opiate analgesia. The GDT
intervention group patients received intravenous fluid and
inotropic therapy according to an algorithm (Supplementary
Figure S1) targeting each patient’s individualized preoperative
oxygen delivery value. If the preoperative oxygen delivery target
was not met after the first hour of stroke volume optimization
using gelatine colloid, an intravenous infusion of dobutamine
(1–20 lg/kg/min) was commenced but strictly limited by heart
rate parameters (<100 bpm, and/or25% from baseline heart
rate at the start of the intervention period). No starches were
used. Cardiac output monitoring was not used in the
protocolized standard of care group, but all variables were
recorded. Calculation of oxygen delivery values was delayed
until the end of the trial in the control group. Achievement of
preoperative oxygen delivery was defined by analysing mean
oxygen delivery throughout the intervention period, and
relating this value to the number of predefined hourly
timepoints during the intervention where postoperative oxygen
delivery met, or exceeded, preoperative values [13]. All other
aspects of clinical care were managed by intensive care unit
(ICU) clinicians who could alter any aspect of patient care,
provided the site principal and/or chief investigator was
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informed if haemodynamic management during the study
intervention period was involved directly. Postoperative
management adhered to enhanced recovery hospital protocols.
Antibiotic use beyond prophylactic administration (i.e. after
24 h post-operatively) was a deviation from normal postopera-
tive care.
Outcomes
The primary outcome was creatinine rise within 48 h postopera-
tively stratified by postoperative haemodynamic intervention
arm. Creatinine rise refers to any creatinine value during the
first 48 h postoperatively that exceeded the preoperative value
for an individual patient. Creatinine fall refers to creatinine val-
ues that were persistently lower throughout the first 48 h post-
operatively, compared with preoperative values for each
individual patient. Secondary end points were development of
AKI, MCR, haemodynamic characteristics, time to become mor-
bidity free and hospital stay associated with AKI. We diagnosed
AKI within the first 48 h postoperatively using changes in creati-
nine and/or oliguria, according to KDIGO criteria. MCR was
defined similarly to other studies, whereby creatinine values
during the first 48 h postoperatively exceeded the preoperative
value for an individual patient, but were below KDIGO-defined
criteria for a significant creatinine rise. We calculated the Acute
Physiology and Chronic Health Evaluation II (APACHE II) score
for each patient, which indicates the severity of acute physio-
logical derangement following surgery. Lactate and C-reactive
protein (CRP) were also measured as markers for tissue perfu-
sion and systemic inflammation, respectively.
Statistical analyses
The primary objective of this trial was to establish whether indi-
vidualized oxygen-delivery therapy reduced postoperative mor-
bidity within the first 48 h postoperatively. On the basis of
previous studies,60% of patients on postoperative day 2 sus-
tain significant morbidity [15, 16]. The sample size calculation
(STATA version 10) has been detailed previously; briefly, at a
statistical significance level of 5%, with a power of 80%, we esti-
mated that at least 102 patients per treatment group would be
required (allowing for 15% of patients to achieve their oxygen
delivery target regardless of intervention, and taking into
account a further 20% dropout rate as a result of failure to
adhere to the protocol and/or intraoperative withdrawals).
Analyses were performed according to an a priori statistical
analysis plan including all patients on an intention to treat
basis, regardless of protocol compliance. Repeated-measures
ANOVA was undertaken to compare haemodynamic changes
between patients who developed AKI, or maintained normal
renal function, at preoperative and postoperative (intervention)
timepoints. Results of primary and secondary outcomes are
reported as relative risks (RRs) with 95% confidence intervals
(CIs). The Kaplan–Meier method was used to summarize time to
become morbidity free and length of hospital stay, with the log-
rank test used to analyse significant differences in time to
event. Multiple logistic regression analysis was performed to
assess associations between the primary outcome (creatinine
rise within 48 h postoperatively), preoperative factors (age, gen-
der, body mass index, cardiac comorbidity, preoperative creati-
nine, type of surgery) and perioperative management
(requirement for norepinephrine, packed red cell transfusion,
lactate at end of operation, randomization arm, oxygen delivery
target achieved, gelatin dose, systemic inflammation as
reflected by CRP). Continuous variables are presented as mean
(standard deviation) or median (quartiles), depending on nor-
mality of distribution. Categorical variables are presented as n
(%). Analyses were performed using NCSS 8 (Kaysville, UT, USA).
Significance was set at P 0.05 (two-tailed).
Results
Patient population
The study was conducted from 20 May 2010 until 12 February
2014, with 204 patients randomly assigned to receive postopera-
tively either haemodynamic therapy designed to restore/main-
tain their individualized preoperative oxygen delivery (n¼ 95) or
protocolized care (n¼ 92; Figure 1). As detailed previously, 17
patients did not undergo the postoperative trial intervention as
they developed exclusion criteria during the intraoperative
period. Thus, we analysed data for 187 patients, with no further
loss to follow up. Demographic characteristics were similar
between groups (Table 1).
Primary endpoint
Postoperative reductions in serum creatinine were similar
(P¼ 0.76) in patients randomized to GDT [10 mmol L1 (95% CI: 17
to 1)] and protocolized care [8 mmol/L (95% CI: 17 to 6); Figure
2]. Postoperative haemodynamic management was not associ-
ated with the development of MCR [78/187 (41.7%)] or AKI [13/
187 (7.0%)]. Similar proportions of patients who developed MCR
were present in each haemodynamic therapy group (P¼ 0.92;
Table 1). Thirteen patients developed AKI, of whom nine sus-
tained stage 1 AKI. We found no association between AKI [RR:
0.74 (95% CI: 0.20–2.75); P¼ 0.65] or MCR [RR: 1.43 (95% CI: 0.78–
2.63); P¼ 0.24] and the trial-protocol-defined use of dobutamine
postoperatively.
Secondary clinical endpoints
Achievement of preoperative oxygen delivery was associated
with a lower incidence of AKI [RR: 1.91 (95% CI: 1.18–3.09);
P¼ 0.03], but not MCR [RR: 1.33 (95% CI: 0.86–2.05); P¼ 0.21],
regardless of postoperative haemodynamic management. Six
out of 95 patients developed AKI in the haemodynamic therapy
group whereas 7/92 patients sustained AKI in the control group
[RR: 1.21 (95% CI: 0.42–3.45); P¼ 0.77]. Markers of systemic
inflammation were similar between groups (Supplementary
Figure S2).
Length of hospital stay
Early AKI was associated with delay in time to become morbid-
ity free [unadjusted hazard ratio: 1.76 (95% CI: 1.12–2.76);
P¼ 0.02] and prolonged hospital stay [hazard ratio: 1.91 (95% CI:
1.23–2.94); P¼ 0.02; Figure 3]. Prolonged hospital stay was associ-
ated with AKI but not MCR [RR: 1.23 (95% CI: 0.91–1.68); P¼ 0.16].
Early AKI was not related to operation type (P¼ 0.99) or chronic
kidney disease [RR: 1.37 (95% CI: 0.39–4.87); P¼ 0.65].
Haemodynamic endpoints
Both AKI [RR: 2.41 (95% CI: 1.24–4.67); P¼ 0.02] and MCR [RR: 1.94
(95% CI: 1.04–3.62); P¼ 0.03] were associated with intraoperative
requirement for norepinephrine to maintain mean arterial
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pressure (MAP), despite similar volumes of intraoperative fluid
being administered (Table 2). By the end of the intraoperative
period, venous lactate (P¼ 0.001) was higher in patients who
went on to develop AKI (Supplementary Figure S3). At the end of
the postoperative period, cardiac output (P¼ 0.66) and absolute
oxygen delivery (P¼ 0.89) were similar between patients who
developed, or avoided, MCR or AKI (Supplementary Figure S3).
The difference in lactate between patients who developed AKI
and those that did not persisted throughout the intervention
period (P¼ 0.009), despite similar cardiac output and oxygen
Table 1. Baseline patient characteristics
Standardized care GDT
Creatinine fall (n ¼ 65) Creatinine rise (n ¼ 27) Creatinine fall (n ¼ 70) Creatinine rise (n ¼ 25)
Age (years) 68 6 10 69 6 6 68 6 10 69 6 7
Male 38 (58%) 18 (67%) 41 (59%) 17 (68%)
BMI (kg m2) 275 6 54.8 281 6 5.5 276 6 5.8 274 6 4.5
Malignancy 45 (69%) 19 (70%) 47 (67%) 17 (68%)
CKD stage 3 10 (15%) 2 (7%) 9 (13%) 6 (24%)
Diabetes mellitus 14 (22%) 6 (22%) 15 (21%) 4 (16%)
Hypertension 30 (46%) 10 (37%) 36 (51%) 15 (60%)
Albumin 43 6 5 42 6 5 42 6 5 42 6 4
CVD 46 (71%) 16 (59%) 55 (79%) 21 (84%)
Surgical procedure
UGI 16 (25%) 5 (19%) 14 (20%) 8 (32%)
Liver/hepatobiliary 25 (38%) 14 (52%) 28 (40%) 8 (32%)
Colorectal 13 (20%) 3 (11%) 17 (24%) 5 (20%)
Vascular 11 (17%) 5 (19%) 8 (11%) 4 (16%)
Data presented as mean6 standard deviation or n (%). BMI, body mass index; UGI, upper gastrointestinal surgery; CKD, chronic kidney disease; CVD, cardiovascular dis-
ease (stroke/ischaemic heart disease/peripheral vascular disease).
Fig. 1. Trial enrollment and analysis plan. RCT, randomized controlled trial.
Acute kidney injury and oxygen delivery | 351
delivery throughout the same time period. Multiple logistic
regression analysis confirmed that failure to achieve preopera-
tive oxygen delivery, use of packed red cells and/or intraopera-
tive requirement for norepinephrine were significantly
associated with increased postoperative creatinine over base-
line values by postoperative day 2 (Table 3).
Discussion
This re-analysis of a prospective randomized controlled,
blinded study failed to demonstrate a benefit of the postopera-
tive GDT on the primary endpoint, postoperative increases in
plasma creatinine. A similar prospective randomized trial also
reported that algorithm-guided goal-directed haemodynamic
therapy failed to improve renal function after major abdominal
surgery compared with normal clinical care [17]. It is notewor-
thy that postoperative interventional trials following noncar-
diac surgery have seldom reported the impact of GDT on renal
morbidity specifically [18]. Furthermore, our study afforded
detailed, serial haemodynamic insight in a randomized con-
trolled setting, hence adding to this literature by providing
detailed haemodynamic profiles on patients randomized to
control care—a feature notably lacking in preceding studies as
highlighted by a preceding systemic review [8]. This analysis
was therefore principally undertaken to contribute to this nota-
ble lack of haemodynamic data reported in control groups, as
highlighted by a preceding systemic review [8]. We acknowledge
that the original study was underpowered to explore
Fig. 2. Oxygen delivery stratified by postoperative creatinine rise and allocation to postoperative haemodynamic intervention. (A) Oxygen delivery, indexed and
expressed as % individualized preoperative value. Mean values (95% CI) shown; numbers per group indicated within figure. Failure to reach preoperative oxygen deliv-
ery was associated with postoperative creatinine rise. Asterisk denotes P¼0.008, for comparison between mean oxygen delivery during intervention period (standar-
dized to each patients’ preoperative value), by ANOVA. Post-hoc analysis showed a mean difference in standardized oxygen delivery between GDT and GDT-creatinine
rise was 22% [(95% CI: 1–45); P¼ 0.05].
Fig. 3. Kaplan–Meier plot showing relationship between development of early AKI and subsequent length of hospital stay.
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mechanisms of AKI alone, but rather as part of the spectrum of
postoperative morbidity that commonly develops in higher-risk
surgical patients.
Our detailed physiological data confirm expert consensus
that even relatively short periods of intraoperative hypotension
requiring vasopressors may contribute to perioperative AKI [19].
These data show that the development of lactataemia and
requirement for pressor support (norepinephrine) precedes the
subsequent development of AKI. However, AKI was not pre-
vented by either GDT or standardized care after the intraopera-
tive development of lactataemia and requirement for pressor
support. These data provide detailed haemodynamic data in
accordance with several studies suggesting that intraoperative
episodes of haemodynamic instability, characterized by relative
hypotension and lower perfusion pressure requiring the intrao-
perative use of norepinephrine, are pathologically implicated in
the development of AKI [20–22]. In addition, we report that
increases in postoperative creatinine below the threshold for
AKI, as defined by KDIGO, do not appear to associate with worse
outcomes. These data are in contrast to cardiac surgery, where
minimal increases in creatinine postoperatively are associated
with excess morbidity and mortality [6, 23].
Packed red blood cell transfusion is also an established peri-
operative risk factor for AKI, at least in cardiac surgery [19]. Each
unit of perioperative blood that is transfused in cardiac surgery
is independently associated with a 10–20% increase in the risk
of AKI [24]. We cannot exclude an additional effect of transfu-
sion on the development of AKI, since patients who developed
AKI were more likely to receive erythrocyte transfusion postop-
eratively. We can also not discount the possibility that the use
of gelatin solutions may increase the risk of bleeding and renal
failure, as highlighted by a recent systematic review [25].
Notably, AKI patients did not differ in pre- or postoperative hae-
moglobin levels, compared with those who did not sustain renal
Table 2. Perioperative clinical management
Standardized care GDT
Creatinine decline Creatinine rise Creatinine decline Creatinine rise
Intraoperative
Duration of surgery (min) 2706105 273 6 125 256 6 98 275 6 117
General anaesthetic only 29 (45%) 14 (52%) 27 (39%) 7 (28%)
Intravenous fluid (mL/kg/h) 13.4 6 9.2 13.9 6 7.4 13.3 6 5.8 12.3 6 5.0
Haemoglobin preoperative 12.9 6 1.7 13.1 6 1.5 12.2 6 1.7 12.9 6 1.3
Haemoglobin postoperative 10.9 6 1.5 10.6 6 1.7 10.6 6 1.5 11.0 6 1.7
Packed red cells [n (%)] 9 (14%) 7 (26%) 18 (26%) 7 (28%)
Vasopressor infusion [n (%)] 13 (20%) 8 (29%) 10 (14%) 8 (32%)
Lactate at end of surgery 1.9 6 1.1 2.2 6 1.2 2.1 6 1.4 2.3 6 1.2
Intervention period
APACHE II score 15 6 5 17 6 6 15 6 6 16 6 5
Gelatin (mL/kg/h) 1.5 6 1.3 2.1 6 2.0 2.9 6 1.7 2.7 6 1.7
Blood transfusion [n (%)] 7 (11%) 4 (15%) 15 (21%) 7 (28%)
Dobutamine infusion [n (%)] 0 0 22 (31%) 13 (52%)
Data presented as mean 6 standard deviation, median (interquartile range) or n (%). Excludes patients randomized but who met exclusion criteria by the end of their
operation.
Table 3. Multiple logistic regression analysis assessing perioperative factors associated with the development of creatinine rise above preoper-
ative baseline values 48 h after surgery
Independent Regression Standard Wald Wald
variable coefficient error Z-value P-value OR (95% CI)
Intercept 1.35 2.86 0.47 0.64 1.74 (0.01–293)
Preoperative Age 0.01 0.03 0.41 0.69 1.01 (0.95–1.08)
Body mass index 0.01 0.06 0.14 0.89 0.99 (0.89–1.11)
Male gender 0.20 0.56 0.35 0.73 0.82 (0.27–2.49)
Cardiovascular morbidity 0.05 0.65 0.08 0.95 1.05 (0.27–3.40)
Type of surgery 0.38 0.62 0.61 0.54 0.68 (0.20–2.31)
Preoperative creatinine 0.00 0.01 0.50 0.62 1.00 (0.99–1.02)
Intraoperative PRC administered 0.29 0.74 0.39 0.69 1.34 (0.31–5.70)
Norepinephrine required 1.21 0.60 2.00 0.05 3.34 (1.02–10.90)
Gelatin dose 0.15 0.09 1.74 0.08 1.16 (0.98–1.38)
Lactate, EndOp 0.04 0.24 0.18 0.86 1.04 (0.65–1.68)
Postoperative GDT 0.10 0.64 0.15 0.88 1.10 (0.32–3.83)
Gelatin dose 0.14 0.20 0.68 0.50 1.14 (0.77–1.69)
PRC administered 2.01 0.91 2.22 0.03 0.13 (0.02–0.79)
Failure to achieve DO2I 1.28 0.65 1.96 0.05 0.28 (0.08–1.00)
CRP, postoperative day 2 0.00 0.00 0.22 0.82 1.00 (0.99–1.01)
OR, odds ratio; PRC, packed red cells; DO2I, oxygen delivery; EndOp, end of operation.
Acute kidney injury and oxygen delivery | 353
injury. Experimental models show that haeme derived from hae-
moglobin imparts nephrotoxicity to vulnerable kidneys [26], par-
ticularly in older subjects subjected to major systemic
inflammation [27]. We speculate that a 1-hit–2-hit model may
influence the development of AKI in this patient population,
where intraoperative hypotension generated by systemic inflam-
mation that requires pressor support is accompanied by the fur-
ther injurious insult of haeme and nitric oxide consumption [28].
The use of norepinephrine in ICU patients with hypotension
has generated much controversy [29], particularly in the context
of acute renal injury [30]. In our study, the only pressor infusion
used intraoperatively was norepinephrine. During systemic
inflammation, restoration of blood pressure with noradrenaline
may have a nephroprotective effect [31]. Norepinephrine infu-
sion in experimental acute endotoxaemia reverses systemic
hypotension and improves renal blood flow, independent of
perfusion pressure. Norepinephrine increases renal vasodila-
tion through increased systemic blood pressure leading to vaso-
dilatation as a result of decreased renal sympathetic tone
through the baroreceptor response [32]. It remains unclear
whether patients with significant comorbidity under general
anaesthesia require more pressor support to mount such a
response. The hypothesis that a subset of patients have a loss,
or lack of, renal auto-regulatory reserve is supported by detailed
serial renal and cardiac output measurements in cardiac surgi-
cal patients. A disconnect was observed between dose-
dependent increases in cardiac index with norepinephrine, yet
a MAP threshold at which pressure-dependent renal perfusion,
filtration and oxygenation improved [30]. However, very high
doses of norepinephrine have been used to reverse AKI through
renal vasoconstriction in healthy animal models [33, 34]. In sep-
sis, the development of AKI was not associated with changes in
renal blood flow, oxygen delivery or histological appearance,
despite the use of norepinephrine to maintain arterial blood
pressure [35]. These data suggesting strongly that other mecha-
nisms must contribute to septic AKI.
Parasympathetic autonomic dysfunction offers an additional
plausible mechanism that may contribute to perioperative AKI. We
have previously reported that GDT in the same trial is associated
with reduced cardiac (vagal) parasympathetic activity, as revealed
by changes in heart rate variability and despite similar heart rates
between groups [13]. A similar observation in reduced cardiac
(vagal) parasympathetic activity has been described during stress
echocardiography [36, 37]. Furthermore, we have also shown in
separate cohorts of patients that impaired baroreflex dys-
function—which is in part characterized by reduced parasympa-
thetic tone—is also associated with excess morbidity [38, 39].
These autonomic changes may impact on renal dysfunction, since
activation of vagal efferent outflow in a murine preclinical model
of renal ischaemia-reperfusion minimizes injury, mediated by an
anti-inflammatory mechanism requiring nicotinic a7 splenocytes
[40].
The intraoperative development of relative hyperlactataemia
associated with a requirement for pressor support in AKI patients
is not likely to be explained by tissue hypoxia. We found that lac-
tate levels at the end of the operation in patients who subsequently
developed AKI did not correlate with oxygen delivery and persisted
despite targeted haemodynamic therapy. As in septic shock, the
presence of hyperlactataemia following resuscitation does not nec-
essarily indicate oxygen debt but rather a metabolic change com-
patible with elevated aerobic glycolysis [41]. Endotoxaemia, a likely
pathologic mediator in high risk surgery [42], is a potent driver of
increased lactate production that may stimulate aerobic glycolysis
through stimulation of NaþKþATPase activity [41]. Stress
hyperlactataemia as a result of adrenergic stimulation is also likely
to make a major contribution [43].
Strengths of this study included the blinded, protocolized
delivery of postoperative haemodynamic care. Serial analysis of
changes in creatinine was pre-specified in the analysis plan. In
contrast to preceding studies, haemodynamic variables were
also measured in the control group. Significant limitations
include the (predictably) low number of patients who sustained
AKI. This reflects that the original power calculation was based
on all-cause early morbidity (on postoperative day 2) rather
than specifically the incidence of AKI, which is predictably far
lower. However, a substantial number of patients who sus-
tained MCR, a clinically relevant readout which has never fea-
tured in non-cardiac surgical studies previously. A further
limitation is a lack of specific biomarkers for renal injury, which
may provide earlier information that guides haemodynamic
management.
Conclusions
The GDT protocol following major non cardiac surgery employed
in this study doubled the achievement rate of attaining individu-
alized preoperative oxygen delivery values (from 33% to 60%),
but failed to alter the trajectory of postoperative renal injury.
Nevertheless, achievement of preoperative oxygen delivery
appears crucial in order to avoid postoperative kidney injury.
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